Autobahn Labs is a collaboration between a Samsara BioCapital-led investor syndicate and Charles River Laboratories. By combining Samsara's long-term investment philosophy with Charles River's world-class drug discovery and development capabilities we believe we can improve patient health by identifying exciting early-stage academic research projects that can spark the development of new therapeutics.
Company Details
- Employees
- 7
- Address
- Palo Alto, Ca 94301, Us
- Industry
- Biotechnology
- Website
- autobahn-labs.com
- HQ
- Palo Alto, CA
- Competitors
- Voro Therapeutics, Nalo Therapeutics, Inc., MESH Strategic Partnerships, Keck School of Medicine of USC, Launchpad Venture Group, Samsara BioCapital, FGH BioTech, Inc., Evotec, Biotech Connection - Bay Area, Inc., Charles River Laboratories, Astellas Engineered Small Molecules U.K. Ltd..
Autobahn Labs, Inc. Questions
Autobahn Labs, Inc.'s website is autobahn-labs.com
Autobahn Labs, Inc.'s LinkedIn profile is https://www.linkedin.com/company/autobahn-labs-inc
Autobahn Labs, Inc. has
7 employees.
View email and phone details for 7
employees at Autobahn Labs, Inc..
Autobahn Labs, Inc.'s industry is
Biotechnology
Autobahn Labs, Inc.'s top competitors are
Voro Therapeutics,
Nalo Therapeutics, Inc.,
Mesh Strategic Partnerships, Keck School Of Medicine Of Usc,
Launchpad Venture Group,
Samsara Biocapital,
Fgh Biotech, Inc.,
Evotec,
Biotech Connection - Bay Area, Inc.,
Charles River Laboratories,
Astellas Engineered Small Molecules U.k. Ltd..
Autobahn Labs, Inc.'s categories are Biotechnology
